792948-17-5 Usage
Uses
Used in Organic Synthesis:
(S)-2-(Benzyloxycarbonyl-prop-2-ynyl-amino)-but-3-enoic acid methyl ester is used as a building block for the synthesis of complex organic molecules. Its unique structure and functional groups allow for the creation of a wide range of compounds, making it a valuable asset in the field of organic synthesis.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, (S)-2-(Benzyloxycarbonyl-prop-2-ynyl-amino)-but-3-enoic acid methyl ester is used as a key component in the development of new pharmaceuticals. Its versatile structure and reactivity enable the design and synthesis of novel drug candidates with potential therapeutic applications.
Used in Chemical Reactions and Processes:
The prop-2-ynyl amino group in (S)-2-(Benzyloxycarbonyl-prop-2-ynyl-amino)-but-3-enoic acid methyl ester confers unique reactivity to the compound, making it useful for the development of new chemical reactions and processes. This can lead to the creation of innovative synthetic routes and methodologies in the field of chemistry.
Overall, (S)-2-(Benzyloxycarbonyl-prop-2-ynyl-amino)-but-3-enoic acid methyl ester is a versatile and potentially valuable chemical compound with a range of potential applications in various industries, including organic synthesis, medicinal chemistry, and the development of new chemical reactions and processes.
Check Digit Verification of cas no
The CAS Registry Mumber 792948-17-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,9,2,9,4 and 8 respectively; the second part has 2 digits, 1 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 792948-17:
(8*7)+(7*9)+(6*2)+(5*9)+(4*4)+(3*8)+(2*1)+(1*7)=225
225 % 10 = 5
So 792948-17-5 is a valid CAS Registry Number.
792948-17-5Relevant academic research and scientific papers
ARYL, HETEROARY, AND HETEROCYCLIC PHARMACEUTICAL COMPOUNDS FOR TREATMENT OF MEDICAL DISORDERS
-
Page/Page column 423; 425, (2018/09/21)
Complement Factor D inhibitors, pharmaceutical compositions, and uses thereof, as well as processes for their manufacture are provided. The compounds provided include Formula I, Formula II, Formula III, Formula IV, and Formula V, or a pharmaceutically acceptable salt, prodrug, isotopic analog, N-oxide, or isolated isomer thereof, optionally in a pharmaceutically acceptable composition. The inhibitors described herein target Factor D and inhibit or regulate the complement cascade.
Synthetic study of (+)-anthramycin using ring-closing enyne metathesis and cross-metathesis
Kitamura, Tsuyoshi,Sato, Yoshihiro,Mori, Miwako
, p. 9649 - 9657 (2007/10/03)
Synthesis of (+)-anthramycin was examined. A pyrrolobenzodiazepine skeleton could be synthesized by reductive cyclization of pyrrolidine derivative, which was obtained by enyne metathesis. The conjugated enamide ester part of (+)-anthramycin derivative was constructed by cross-metathesis. Graphical Abstract.
